Cargando…

Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria

OBJECTIVE: The aim of this study was to describe the renal arteries of humans in vivo, as precisely as possible, and to formulate an expected value for the exclusion of renal denervation due to the anatomical situation based on the criteria of the Symplicity HTN trials. DESIGN AND SETTING: In a retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schönherr, Elisabeth, Rehwald, Rafael, Nasseri, Parinaz, Luger, Anna K, Grams, Astrid E, Kerschbaum, Julia, Rehder, Peter, Petersen, Johannes, Glodny, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Renal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716171/ https://www.ncbi.nlm.nih.gov/pubmed/26729385 http://dx.doi.org/10.1136/bmjopen-2015-009351

Ejemplares similares

Renal denervation after the symplicity HTN-3 trial
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2014)

Renal Denervation after Symplicity HTN-3: An Update
por: Persu, Alexandre, et al.
Publicado: (2014)

SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
por: Patel, Hitesh C, et al.
Publicado: (2014)

Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
por: Fadl Elmula, Fadl Elmula M., et al.
Publicado: (2015)

Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure
por: Lurz, Philipp, et al.
Publicado: (2019)

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2017)

SYMPLICITY HTN-3 results to be announced: a mystery or a story foretold?
por: Staessen, Jan A, et al.
Publicado: (2014)

Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV‐Risk Study
por: Solbu, Marit D., et al.
Publicado: (2021)

Catheter‐based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension
por: Liu, Senyan, et al.
Publicado: (2022)

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry
por: Schmieder, Roland E, et al.
Publicado: (2022)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study
por: Saxena, Manish, et al.
Publicado: (2021)

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
por: Kirtane, Ajay J., et al.
Publicado: (2023)

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2019)

A Japan nationwide web‐based survey of estimation on patients for renal denervation based on blood pressure level and the number of antihypertensives (J‐NEEDs survey)
por: Kagitani, Hideaki, et al.
Publicado: (2021)

Thirty‐six‐month results of laparoscopic‐based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone‐producing adenoma
por: Liu, Yahui, et al.
Publicado: (2021)

Con: Renal denervation for all resistant hypertensive patients: the Emperor's new clothes
por: Persu, Alexandre, et al.
Publicado: (2014)

Is lack of suitable housing a barrier to home-based dialysis therapy for patients with end-stage renal disease? A cohort study
por: Forbes, Suzanne H, et al.
Publicado: (2013)

RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition
por: Koszegi, Sandor, et al.
Publicado: (2018)

Prognostic factors in endovascular treated pelvic haemorrhage after blunt trauma
por: Rehwald, Rafael, et al.
Publicado: (2017)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Khanal, Suraj, et al.
Publicado: (2014)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Worthley, Stephen G., et al.
Publicado: (2013)

Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
por: Honarvar, Mehrdad, et al.
Publicado: (2013)

Supernumerary kidneys: a clinical and radiological analysis of nine cases
por: Rehder, Peter, et al.
Publicado: (2019)

Preoperative Renal Parenchyma Volume as a Predictor of Kidney Function Following Nephrectomy of Complex Renal Masses
por: Antony, Maria B., et al.
Publicado: (2023)

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial
por: Weber, Thomas, et al.
Publicado: (2022)

Exogenous and endogenous angiotensin‐II decrease renal cortical oxygen tension in conscious rats by limiting renal blood flow
por: Emans, Tonja W., et al.
Publicado: (2016)

Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation Registry
por: Zweiker, David, et al.
Publicado: (2016)

Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA
por: Cravedi, Paolo, et al.
Publicado: (2012)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

Impact of Hospital Volume on the Outcomes of Renal Trauma Management
por: Baloche, Paul, et al.
Publicado: (2022)

Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study – a randomized controlled trial
por: Oliveras, Anna, et al.
Publicado: (2016)

Human renal response to furosemide: Simultaneous oxygenation and perfusion measurements in cortex and medulla
por: Haddock, Bryan, et al.
Publicado: (2019)

EP(1) receptor antagonism mitigates early and late stage renal fibrosis
por: Kresse, Jean‐Claude, et al.
Publicado: (2022)

Incidence of and Risk Factors for Recurrent Urinary Tract Infections in Renal Transplant Recipients
por: Halskov, Anna C.L., et al.
Publicado: (2023)

Non-adherence to immunosuppressants following renal transplantation: a protocol for a systematic review
por: Hucker, Abigail, et al.
Publicado: (2017)

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort
por: Roccatello, Dario, et al.
Publicado: (2017)

How can we make renal medicine careers more appealing to UK trainees?
por: Karangizi, Alvin H K, et al.
Publicado: (2019)

Monthly variance in UK renal transplantation activity: a national retrospective cohort study
por: Lowe, Marcus, et al.
Publicado: (2019)

Impact of air pollution on renal outcomes: a systematic review and meta-analysis protocol
por: Hamroun, Aghilès, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9t6bp2cifnc4u00kd7f1oj9ns5